Shanghai Yizhong Pharmaceutical Co Ltd (688091) — Free Cash Flow Generation Index
Shanghai Yizhong Pharmaceutical Co Ltd (688091) has a Free Cash Flow Generation Index of -0.44x as of September 2025. Free cash flow of CN¥-9.33 Million represents 0% of operating cash flow (CN¥21.03 Million). See Shanghai Yizhong Pharmaceutical Co Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Shanghai Yizhong Pharmaceutical Co Ltd Free Cash Flow Generation Index (2022–2024)
Historical FCF Generation Index trend for Shanghai Yizhong Pharmaceutical Co Ltd across 3 annual periods. Explore debt repayment capacity of Shanghai Yizhong Pharmaceutical Co Ltd to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Shanghai Yizhong Pharmaceutical Co Ltd (2022–2024)
Year-by-year Free Cash Flow Generation Index for Shanghai Yizhong Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Shanghai Yizhong Pharmaceutical Co Ltd market capitalisation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.03x | CN¥-40.60 Million | CN¥39.44 Million | CN¥80.04 Million | ▼ -214.6% |
| 2023 | 0.90x | CN¥77.77 Million | CN¥86.55 Million | CN¥8.78 Million | ▲ +32.9% |
| 2022 | 0.68x | CN¥74.90 Million | CN¥110.78 Million | CN¥35.88 Million | — |